Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheina Emrani

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Journal of Alzheimer'S Disease : JAD|July 5, 2021
Neurocognitive Constructs Underlying Executive Control in Statistically-Determined Mild Cognitive ImpairmentSheina Emrani, Melissa Lamar, Catherine Price, et al.
Journal of Clinical and Experimental Neuropsychology|January 25, 2020
Visuospatial performance in patients with statistically-defined mild cognitive impairmentVictor Wasserman, Sheina Emrani, Emily F Matusz, et al.
Plos One|July 29, 2016
3D Visualization of the Temporal and Spatial Spread of Tau Pathology Reveals Extensive Sites of Tau Accumulation Associated with Neuronal Loss and Recognition Memory Deficit in Aged Tau Transgenic MiceHongjun Fu, S Abid Hussaini, Susanne Wegmann, et al.
Innovation in Aging|May 9, 2019
Visual and Verbal Serial List Learning in Patients with Statistically-Determined Mild Cognitive ImpairmentVictor Wasserman, Sheina Emrani, Emily F Matusz, et al.
Journal of Alzheimer'S Disease : JAD|April 22, 2025
Precision neurocognition: An emerging diagnostic paradigm leveraging digital cognitive assessment technologyDavid J Libon, Rodney Swenson, Dianne Teresa Langford, et al.
Journal of Alzheimer'S Disease : JAD|February 9, 2026
Digital neuropsychological assessment-Part 2: Relations with cardiovascular risk and informant ratings of neurocognitive decline, functional disabilities, and psychiatric symptomsDavid J Libon, Rod Swenson, Sean Tobyne, et al.
Journal of the International Neuropsychological Society : JINS|September 20, 2024
Psychometric and adherence considerations for high-frequency, smartphone-based cognitive screening protocols in older adultsLouisa I Thompson, Alyssa N De Vito, Zachary J Kunicki, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 29, 2023
Remote and in-clinic digital cognitive screening tools outperform the MoCA to distinguish cerebral amyloid status among cognitively healthy older adultsLouisa I Thompson, Zachary J Kunicki, Sheina Emrani, et al.
Alzheimer'S Research & Therapy|July 6, 2024
Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's diseaseMatthew D Howe, Karysa J Britton, Hannah E Joyce, et al.
Journal of Alzheimer'S Disease : JAD|February 9, 2026
Digital neuropsychological assessment-part 1: Defining mild cognitive impairment subtypesDavid J Libon, Deborah Drabick, Rod Swenson, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Journal of Alzheimer'S Disease : JAD|July 5, 2021
Neurocognitive Constructs Underlying Executive Control in Statistically-Determined Mild Cognitive ImpairmentSheina Emrani, Melissa Lamar, Catherine Price, et al.
Journal of Clinical and Experimental Neuropsychology|January 25, 2020
Visuospatial performance in patients with statistically-defined mild cognitive impairmentVictor Wasserman, Sheina Emrani, Emily F Matusz, et al.
Plos One|July 29, 2016
3D Visualization of the Temporal and Spatial Spread of Tau Pathology Reveals Extensive Sites of Tau Accumulation Associated with Neuronal Loss and Recognition Memory Deficit in Aged Tau Transgenic MiceHongjun Fu, S Abid Hussaini, Susanne Wegmann, et al.
Innovation in Aging|May 9, 2019
Visual and Verbal Serial List Learning in Patients with Statistically-Determined Mild Cognitive ImpairmentVictor Wasserman, Sheina Emrani, Emily F Matusz, et al.
Journal of Alzheimer'S Disease : JAD|April 22, 2025
Precision neurocognition: An emerging diagnostic paradigm leveraging digital cognitive assessment technologyDavid J Libon, Rodney Swenson, Dianne Teresa Langford, et al.
Journal of Alzheimer'S Disease : JAD|February 9, 2026
Digital neuropsychological assessment-Part 2: Relations with cardiovascular risk and informant ratings of neurocognitive decline, functional disabilities, and psychiatric symptomsDavid J Libon, Rod Swenson, Sean Tobyne, et al.
Journal of the International Neuropsychological Society : JINS|September 20, 2024
Psychometric and adherence considerations for high-frequency, smartphone-based cognitive screening protocols in older adultsLouisa I Thompson, Alyssa N De Vito, Zachary J Kunicki, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 29, 2023
Remote and in-clinic digital cognitive screening tools outperform the MoCA to distinguish cerebral amyloid status among cognitively healthy older adultsLouisa I Thompson, Zachary J Kunicki, Sheina Emrani, et al.
Alzheimer'S Research & Therapy|July 6, 2024
Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's diseaseMatthew D Howe, Karysa J Britton, Hannah E Joyce, et al.
Journal of Alzheimer'S Disease : JAD|February 9, 2026
Digital neuropsychological assessment-part 1: Defining mild cognitive impairment subtypesDavid J Libon, Deborah Drabick, Rod Swenson, et al.
Pageof 6